Bain Capital Life Sciences Fund II, L.P. 13D/13G Filings for Syros Pharmaceuticals, Inc. (SYRS)

Bain Capital Life Sciences Fund II, L.P. 13D and 13G filings for Syros Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2022-02-14
06:41 am
Purchase		 2021-12-31 13G Syros Pharmaceuticals, Inc.
SYRS		 Bain Capital Life Sciences Fund II, L.P. 626,442
11.000%		 47,938increase
(+8.29%)		 Filing
2020-12-14
5:12 pm
Purchase		 2020-12-08 13G Syros Pharmaceuticals, Inc.
SYRS		 Bain Capital Life Sciences Fund II, L.P. 578,504
11.000%		 578,504increase
(New Position)		 Filing